pargyline has been researched along with vanadates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpéné, C; Marti, L; Prévot, D; Visentin, V | 1 |
| Boucher, J; Bour, S; Carpéné, C; Ordener, C; Parini, A; Prévot, D; Valet, P; Visentin, V | 1 |
2 other study(ies) available for pargyline and vanadates
| Article | Year |
|---|---|
Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates.
Topics: Adipocytes; Amine Oxidase (Copper-Containing); Androstadienes; Animals; Benzylamines; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glutathione; Hydrogen Peroxide; Insulin; Isoproterenol; Lipolysis; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Pargyline; Phosphoinositide-3 Kinase Inhibitors; Quercetin; Rats; Rats, Wistar; Substrate Specificity; Tyramine; Vanadates; Wortmannin | 2003 |
Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Topics: Adipocytes; Adipose Tissue; Amine Oxidase (Copper-Containing); Animals; Benzylamines; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose; Kidney; Lipolysis; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Oxidation-Reduction; Pargyline; Rats; Rats, Wistar; Semicarbazides; Tyramine; Vanadates | 2005 |